Literature DB >> 9425259

Identification of regulatory elements of human alpha 6 integrin subunit gene.

K Nishida1, R Kitazawa, K Mizuno, S Maeda, S Kitazawa.   

Abstract

The integrin alpha 6 subunit associates with either the beta 1 or beta 4 subunit to form receptors for laminin, a major component of the basement membrane. Here, we characterized basal promoter of the human integrin alpha 6 subunit gene. The transcription start site, mapped by primer extension analysis, was 208 bp upstream of the translation start site. The promoter region lacked canonical TATA and GC boxes, but did contain a TATA-like sequence (GATAAA) 23 bp upstream of the major transcription start site. Consensus binding sites for Sp1 and the NF-kappa B complex were also present in the promoter region. A putative glucocorticoid/progesterone receptor responsive element (GRE/PRE), together with the Ap1 and c-myc binding sites located around 350-360 bp upstream of the transcription start site, represented positive regulatory sequences. Our current study showed a molecular model by which progesterone promotes tumor cell invasion through the basement membrane by up-regulating the laminin receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9425259     DOI: 10.1006/bbrc.1997.7808

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 2.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

3.  Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells.

Authors:  R Mukhopadhyay; R L Theriault; J E Price
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

4.  Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium.

Authors:  Carola Förster; Sari Mäkela; Anni Wärri; Silke Kietz; David Becker; Kjell Hultenby; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

5.  The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.

Authors:  Laura E Lamb; Jelani C Zarif; Cindy K Miranti
Journal:  Cancer Res       Date:  2011-02-10       Impact factor: 12.701

6.  Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway.

Authors:  Jennifer A Markovics; Jun Araya; Stephanie Cambier; David Jablons; Arthur Hill; Paul J Wolters; Stephen L Nishimura
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

7.  Disruption of Smad4 in mouse epidermis leads to depletion of follicle stem cells.

Authors:  Leilei Yang; Lijuan Wang; Xiao Yang
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

8.  Parathyroid hormone-related protein regulates integrin α6 and β4 levels via transcriptional and post-translational pathways.

Authors:  Vandanajay Bhatia; Ramanjaneya V R Mula; Miriam Falzon
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

Review 9.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

10.  Neuronal c-Jun is required for successful axonal regeneration, but the effects of phosphorylation of its N-terminus are moderate.

Authors:  Crystal A Ruff; Nils Staak; Smriti Patodia; Mark Kaswich; Eridan Rocha-Ferreira; Clive Da Costa; Stephan Brecht; Milan Makwana; Xavier Fontana; Mariya Hristova; Prakasham Rumajogee; Matthias Galiano; Marion Bohatschek; Thomas Herdegen; Axel Behrens; Gennadij Raivich
Journal:  J Neurochem       Date:  2012-03-21       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.